Literature DB >> 9719883

Uterine artery embolization for the treatment of uterine fibroids.

S C Goodwin1, W J Walker.   

Abstract

The first reported cases of uterine artery embolization in obstetric and gynaecological practice were carried out in the late 1970s. Recently, bilateral uterine artery embolization was used as a primary treatment for fibroids. Meticulous preoperative assessment is essential. The technique of uterine artery embolization involves the catheterization of both uterine arteries and the installation of tiny micro particles of polyvinyl alcohol. Following the procedure, post-procedural pain occurs within the first 24 h and most patients are advised to rest for 1 week. In the UCLA and RSCH series, three infective complications occurred leading to hysterectomy and some patients developed amenorrhoea. Average shrinkage of fibroids in the UCLA, RSCH and French series were 40%, 64% and 70%, respectively, with most patients losing their symptoms and being satisfied with the procedure. Meticulous pre-operative assessment is essential. At UCLA, 140 patients, and at RSCH, 96 patients have been embolized. To date in the UK, US and French series, fibroid growth has been arrested and new fibroids have not formed. However, long-term follow-up on a larger number of cases will be required before the role of uterine artery embolization in the gynaecologic therapeutic armamentarium can be fully defined.

Entities:  

Mesh:

Year:  1998        PMID: 9719883     DOI: 10.1097/00001703-199808000-00006

Source DB:  PubMed          Journal:  Curr Opin Obstet Gynecol        ISSN: 1040-872X            Impact factor:   1.927


  9 in total

Review 1.  [Risk and complication rate of uterine fibroid embolization (UFE)].

Authors:  B Radeleff; S Rimbach; G W Kauffmann; G M Richter
Journal:  Radiologe       Date:  2003-08       Impact factor: 0.635

2.  Uterine Artery Embolization in the Management of Symptomatic Uterine Fibroids: An Overview of Complications and Follow-up.

Authors:  Tami C Carrillo
Journal:  Semin Intervent Radiol       Date:  2008-12       Impact factor: 1.513

3.  Complications of embolization.

Authors:  José I Bilbao; Antonio Martínez-Cuesta; Femín Urtasun; Octavio Cosín
Journal:  Semin Intervent Radiol       Date:  2006-06       Impact factor: 1.513

Review 4.  Gene therapy of benign gynecological diseases.

Authors:  Memy H Hassan; Essam E Othman; Daniela Hornung; Ayman Al-Hendy
Journal:  Adv Drug Deliv Rev       Date:  2009-05-13       Impact factor: 15.470

Review 5.  Image-guided thermal therapy of uterine fibroids.

Authors:  Shu-Huei Shen; Fiona Fennessy; Nathan McDannold; Ferenc Jolesz; Clare Tempany
Journal:  Semin Ultrasound CT MR       Date:  2009-04       Impact factor: 1.875

6.  Towards fibroid gene therapy: adenovirus-mediated delivery of herpes simplex virus 1 thymidine kinase gene/ganciclovir shrinks uterine leiomyoma in the Eker rat model.

Authors:  Memy Hassan; Dong Zhang; Salama Salama; Farid Hamada; Hossam Arafa; Hala Fouad; Cheryl Walker; Ayman Al-Hendy
Journal:  Gynecol Obstet Invest       Date:  2009-03-27       Impact factor: 2.031

7.  Fibroid-induced acute urinary retention: treatment by uterine artery embolization.

Authors:  Elizabeth Kagan Arleo; Michael G Tal
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-10-02

8.  Angiographic embolization of a postpartum vulvovaginal hematoma in a patient with situs inversus totalis: an effective second-line treatment.

Authors:  Elias M Dahdouh; Jacques Balayla; Johanne Dubé
Journal:  Case Rep Obstet Gynecol       Date:  2013-06-20

9.  Uncommon Complication of Uterine Artery Embolization: Expulsion of Infarcted Myoma and Uterine Sepsis.

Authors:  Juliana G Martins; Dawn Gaudenti; Frank Crespo; Dervi Ganesh; Usha Verma
Journal:  Case Rep Obstet Gynecol       Date:  2016-03-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.